Clinical Trials Logo
  1. Home
  2. Critically Ill
  3. NCT05112328
  4. Details
NCT05112328 Clinical Trial

The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding

Critically Ill Clinical Trial

— PREZENT  

Official title:
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding: Prospective Randomized Controlled Trial

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05112328
Other study ID # 2008-185-1153
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 7, 2021
Est. completion date July 31, 2026

Study information
Verified date November 2021
Source Seoul National University Hospital
Contact Oh
Phone +82-2-2072-3538
Email faun1226@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Determine the effect of high-dose pancreatic enzyme supplementation on nutritional indicators and clinical course in critically ill patients undergoing enteral nutrition.

Recruitment information / eligibility
Status Recruiting
Enrollment 170
Est. completion date July 31, 2026
Est. primary completion date July 31, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adults 19 years and older - Hospitalized in the surgical/medical intensive care unit of the Seoul National University Hospital - Enteral nutrition - Patients who consented to this study - Patients with risk factors for pancreatic exocrine dysfunction - Shock (Norepinephrine) - Sepsis (3 rd definition of sepsis) - Diabetes - Cardiac arrest - hyperlactatemia serum lactate > 2 mmol/L) - Mechanical ventilation - Continuous renal replacement therapy Exclusion Criteria: - chronic pancreatitis - unresectable pancreatic cancer - History of pancreatectomy - Underlying diseases in which the effect of Exocrine pancreatic enzyme administration is difficult to show - Inflammatory bowel disease - Short bowel syndrome

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Exocrine Pancreatic Enzyme
Pancreatic enzyme supplementation for critically ill patients on enteral nutrition
• Placebo
Placebo of Pancreatic enzyme for critically ill patients on enteral nutrition

Locations
Country Name City State
Korea, Republic of Seoul National University Hospital Seoul Jongno-gu

Sponsors (1)
Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Change of Phase angle (°) Change from Baseline Phase angle (°) at 2 weeks or discharge Baseline, 7 days after starting enteral nutrition, 14 days after starting enteral nutrition
Secondary Skeletal Muscle Mass (SMM) (kg) Skeletal Muscle Mass (SMM) (kg) Baseline, 7 days after starting enteral nutrition, 14 days after starting enteral nutrition
See also
  Status Clinical Trial Phase
Recruiting NCT05539521 - Efficacy and Safety of Remimazolam Besylate Versus Propofol for Sedation in Critically Ill Patients With Deep Sedation Phase 2
Recruiting NCT04776486 - Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance N/A
Recruiting NCT05766319 - The ICU-recover Box, Using Smart Technology for Monitoring Health Status After ICU Admission N/A
Recruiting NCT03231540 - The PREServation of MUScle Function in Critically Ill Patients (PRESMUS) N/A
Completed NCT02286869 - Cardioventilatory Coupling in Critically Ill Patients N/A
Completed NCT01434823 - 24 Hour Intensivist Coverage in the Medical Intensive Care Unit N/A
Active, not recruiting NCT01142570 - Effect of Enteral Nutrition Enriched in Protein and Based on Indirect Calorimetry Measurement in Chronically Critically Ill Patients N/A
Completed NCT01167595 - Enhanced Protein-Energy Provision Via the Enteral Route in Critically Ill Patients N/A
Completed NCT01293708 - Realities, Expectations and Attitudes to Life Support Technologies in Intensive Care for Octogenarians:
Not yet recruiting NCT00916591 - Prokinetic Drugs and Enteral Nutrition N/A
Recruiting NCT00654797 - Improving Blood Glucose Control With a Computerized Decision Support Tool: Phase 2 Phase 2
Withdrawn NCT00178321 - Improving Sleep in the Pediatric Intensive Care Unit N/A
Completed NCT01168128 - PERFormance Enhancement of the Canadian Nutrition Guidelines by a Tailored Implementation Strategy: The PERFECTIS Study N/A
Completed NCT02447692 - Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study N/A
Recruiting NCT04582760 - Early Mobilization in Ventilated sEpsis & Acute Respiratory Failure Study N/A
Not yet recruiting NCT05961631 - Bio-electrical Impedance Analysis Derived Parameters for Evaluating Fluid Accumulation
Completed NCT03276650 - Admission of Adult-onset Still Disease Patients in the ICU
Completed NCT03922113 - Muscle Function After Intensive Care
Recruiting NCT05055830 - Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
Recruiting NCT06027008 - Mechanical Insufflation-Exsufflation (Cough Assist) in Critically Ill Adults N/A